🔬ASM Microbe 2024 - A Decade of Progress and Perseverance - Navigating HCV Resistance in the DAA Era

Welcome to the in-depth presentation, "A Decade of Progress and Perseverance - Navigating HCV Resistance in the DAA Era." In this video, Dr. FakhriRavari, an Associate Professor at Loma Linda University School of Pharmacy, explores the significant advancements and ongoing challenges in the treatment of Hepatitis C virus (HCV) over the past decade.
🩺 This presentation covers:
- The evolution of Direct-Acting Antivirals (DAAs) since their introduction more than ten years ago.
-Mechanisms of HCV resistance and how they impact treatment outcomes.
Strategies for managing and overcoming resistance in clinical practice.
Designed for healthcare professionals, students, and anyone interested in the latest developments in HCV treatment, this presentation provides valuable insights into the dynamic field of antiviral therapy.
👍 Don't forget to like, comment, and subscribe for more educational content on HCV and other infectious diseases. Share this video with colleagues and peers who might find it informative.
🐦 Twitter: LordAlirezaF
💼 LinkedIn: / alireza-fakhriravari-p...
🌐 Website: www.DrFakhriRavari.com